Search results
A Life-long Asthma Patient Shares How She’s Learned to Manage Her Condition
Parade via Yahoo News· 12 months agoRashelle Stocker was diagnosed with asthma in third grade after having her first attack on the...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 1 month agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The...
See price hikes for top 25 drugs covered by Medicare; NJ drugmakers sue to stop change
App.com | Asbury Park Press via Yahoo Finance· 9 months agoAverage prices for 25 widely used drugs covered by Medicare more than tripled since they were...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 11 hours agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
GSK to cap out-of-pocket inhaler costs in US
Reuters via Yahoo News· 1 month agoThe cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Innoviva Inc (NASDAQ:INVA) reported a 35% year-over-year increase in net product revenues...
GSK Gears Up to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report fourth-quarter 2022 results on Feb 1, before the opening bell. In the last...
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
Zacks via Yahoo Finance· 1 month agoGSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month...